(NASDAQ:KMTS), KIRKLAND, Wash., Oct. 28, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the Stifel 2025 Healthcare Conference on Tuesday, November 11 at 3:20 p.m. Eastern Time. Interested parties may access the live webcast and replay of the presentation by […]
TeraWulf Expands Strategic Partnership with Fluidstack Through New 168 MW AI Compute Joint Venture GlobeNewswire October 28, 2025 25-year lease agreement represents approximately $9.5 billion in contracted revenue Google backstops $1.3 billion of Fluidstack's long-term lease obligations in support of project debt Exclusive right to partner with Fluidstack on next ~168 MW critical IT load
ORLANDO, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has been awarded a Top Workplaces 2025 honor by Orlando Top Workplaces. This list is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The confidential,
(NASDAQ:CRVO), Mr. Quigley most recently led McKinsey & Company's Private Capital practice and previously led various Life Sciences practices at the firm Appointment adds deep business strategy, transactional, and commercial expertise as CervoMed prepares for Phase 3 and commercialization planning BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO) (CervoMed or the Company),
TeraWulf Reports Preliminary Third Quarter 2025 Financial Results Strong year-over-year growth reflects strategic repositioning to HPC hosting and continued growth momentum GlobeNewswire October 28, 2025 EASTON, Md., Oct. 28, 2025 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced preliminary
(Other OTC:GAMI),(OTC US:GAMI),(NYSE:AAP),(NYSE:AN),(NYSE:AZO),(NYSE:DAN),(NYSE:DCI),(NASDAQ:DORM),(NASDAQ:GTX),(NASDAQ:GNTX),(NASDAQ:LKQ),(NASDAQ:MNRO),(NASDAQ:MPAA),(NYSE:MP),(NASDAQ:NNBR),(NASDAQ:ORLY),(NYSE:PAG),(NYSE:PHIN),(NYSE:SAH),(NYSE:SMP),(NasdaqGM:STRT),(NYSE:GPC),(NASDAQ:RUSHB), GREENWICH, Conn., Oct. 28, 2025 (GLOBE NEWSWIRE) — Gabelli Funds will host its 49th Annual Automotive Symposium on November 3rd and 4th, 2025 at the Encore at Wynn in Las Vegas, Nevada. This two-day symposium will feature presentations by senior management of leading automotive and trucking companies, with a lineup that allows
PMGC Holdings Inc.'s Subsidiary, AGA Precision Systems LLC, Completes Acquisition of Indarg Engineering, Inc. Expanding Aerospace and Defense Manufacturing Platform GlobeNewswire October 28, 2025 Strategic Acquisition Accelerates PMGC's U.S. Manufacturing Roll-Up, Expanding Footprint Across Aerospace and Industrial Supply Chains Acquisition Adds Profitable CNC Platform with Established Customer Relationships to drive earnings scalability and operational synergies
(NASDAQ:RXRX), Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 financial results on Wednesday, November 5, 2025, before the open of the financial markets. Recursion will
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers GlobeNewswire October 28, 2025 First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — ModeX
ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs GlobeNewswire October 28, 2025 To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE)